Medical affairs (MA) is rapidly evolving into a strategic, data-driven function that plays a central role in transforming healthcare systems and advancing healthcare innovation. No longer limited to a supporting or compliance role, it is becoming a key driver in connecting scientific innovation with real-world patient outcomes.
In 2026, the focus is not just on generating evidence, but on ensuring that evidence leads to action.
This perspective was shared by Thomas Lanz at the recent Next Medical Festival, where he emphasized the importance of shifting toward measurable impact, and a clear vision of Medical Affairs.
Medical Affairs becomes “beautiful” when it translates scientific innovation into real patient outcomes.
At its core, medical affairs is about connecting breakthroughs in science with patients who need them. Seeing a tumor shrink in a patient after treatment or a rare skin condition improve dramatically highlights the impact of modern healthcare innovation and clinical progress.
However, there is a paradox. While these treatments exist, many patients still cannot access them.
In countries like Germany, some therapies remain unapproved, leaving patients without access despite clear benefits. This gap exposes a critical challenge in improving clinical adoption in healthcare and raises an important question:
Could Medical Affairs have done more to bridge it?
The healthcare system continues to face challenges in translating research into real-world use, highlighting the need for better healthcare data analytics for engagement and evidence utilization.
There is often a 17-year gap between innovation and its adoption in clinical practice. Even more concerning, only about 14% of published evidence is implemented in real-world care.
Additionally, large portions of the population remain undiagnosed—for example, in chronic kidney disease (CKD), up to 85% of patients in the U.S. are not diagnosed.
These gaps highlight the importance of Medical Affairs impact measurement and the need to accelerate clinical adoption to improve real patient outcomes.
Medical affairs should act as a strategic, data-driven function focused on improving patient outcomes and expanding access through a modern Medical Affairs strategy.
Modern MA goes beyond compliance. Instead, it should focus on expanding the “patient funnel”—ensuring more patients are screened, diagnosed, and treated according to guidelines.
This shift aligns medical affairs with broader business goals and healthcare transformation, contributing to both organizational success and better patient care.
A high-performing organization combines mindset, evidence, engagement, and measurement into a continuous improvement loop centered on medical affairs impact measurement.
Three core drivers define excellence:
Data allows medical teams to identify unmet needs and implement effective healthcare data analytics for engagement strategies.
In 2026, data makes it possible to pinpoint where patients are, where diagnoses are lacking, and where care gaps exist. This enables medical teams to focus on improving clinical adoption in healthcare and allocate resources where they have the most impact.
This enables medical teams to:
Data transforms MA from reactive to proactive, enabling targeted and efficient engagement strategies.
Impact is measured by linking activities to changes in clinical behavior and patient outcomes through structured medical affairs impact measurement.
Key performance indicators (KPIs) ensure that every activity is tied to clear objectives, such as:
This approach enables organizations to optimize strategies and demonstrate measurable value.
Medical Affairs, commercial teams, and other functions must work together in cross-functional healthcare environments to achieve shared goals.
While MA focuses on scientific engagement and clinical impact, collaboration ensures a unified approach to patient care and improved healthcare innovation outcomes.
Lifecycle management and ongoing engagement are key to keeping patients on treatment.
A major challenge in healthcare is not just getting patients onto treatment, but keeping them there. Patients often discontinue therapy, creating gaps in care that reduce long-term effectiveness.
This is addressed this by:
This approach ensures that patients remain engaged and continue to benefit from treatments over time.
The ultimate goal is to reduce the gap between scientific innovation and real-world patient care.
MA should not be satisfied with regulatory approval alone. Instead, success should be measured by how many patients actually receive and benefit from treatments.
The vision for 2026 and beyond is clear: Medical Affairs must act as a strategic leader within organizations, accelerating clinical adoption, improving patient access, and ultimately transforming healthcare outcomes.
By embracing data, adopting a strong impact-driven mindset, and aligning with broader organizational goals, medical affairs can truly fulfill its purpose—and demonstrate that, indeed, medical is beautiful.
Data-driven medical engagement strategies use real-world healthcare data to identify unmet needs and guide targeted interactions with healthcare professionals, helping improve decision-making and patient care.
Medical Affairs improves clinical adoption in healthcare by generating relevant evidence, engaging stakeholders, and ensuring that new treatments are understood, accepted, and used in clinical practice.
MA impact measurement is essential because it allows organizations to track the effectiveness of their activities, link actions to outcomes, and demonstrate value through measurable improvements in patient care.
Healthcare data analytics for engagement helps medical teams identify gaps in diagnosis and treatment, prioritize high-need areas, and optimize engagement strategies to improve overall patient outcomes.
MA supports patient retention in treatment strategies by generating ongoing evidence, supporting healthcare professionals, and reinforcing the long-term value of therapies to improve adherence and persistence.
Data-driven approaches improve patient outcomes by enabling more precise targeting, better resource allocation, and more effective engagement strategies based on real-world insights and measurable results.
It supports long-term success by focusing on continuous evidence generation, improving healthcare provider engagement, and promoting strategies that enhance patient adherence and treatment continuity.
